Budget impact analysis of the use of Souvenaid in patients with prodromal Alzheimer’s Disease in Spain

被引：0
|
作者：
Javier Mar
Oliver Ibarrondo
Igor Larrañaga
Lorea Mar-Barrutia
Myriam Soto-Gordoa
机构：
[1] Basque Health Service (Osakidetza),Department of Psychiatry, Osakidetza Basque Health Service
[2] Debagoiena Integrated Healthcare Organisation,Faculty of Engineering, Electronics and Computing Department
[3] Research Unit,undefined
[4] Kronikgune Institute for Health Service Research,undefined
[5] Biodonostia Health Research Institute,undefined
[6] Donostia-San Sebastián,undefined
[7] Unidad de Gestión Sanitaria,undefined
[8] Hospital ‘Alto Deba’,undefined
[9] Araba University Hospital,undefined
[10] Mondragon Unibertsitatea,undefined
来源：
Alzheimer's Research & Therapy | / 14卷
关键词：
Prodromal Alzheimer’s disease; Souvenaid; Budget impact analysis; Dementia; Clinical Dementia Rating;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] Budget impact analysis of the use of Souvenaid in patients with prodromal Alzheimer's Disease in Spain
    Mar, Javier
    Ibarrondo, Oliver
    Larranaga, Igor
    Mar-Barrutia, Lorea
    Soto-Gordoa, Myriam
    ALZHEIMERS RESEARCH & THERAPY, 2022, 14 (01)
  • [2] Economic evaluation of supplementing the diet with Souvenaid in patients with prodromal Alzheimer’s disease
    Javier Mar
    Ania Gorostiza
    Oliver Ibarrondo
    Igor Larrañaga
    Arantzazu Arrospide
    Pablo Martinez-Lage
    Myriam Soto-Gordoa
    Alzheimer's Research & Therapy, 12
  • [3] Economic evaluation of supplementing the diet with Souvenaid in patients with prodromal Alzheimer's disease
    Mar, Javier
    Gorostiza, Ania
    Ibarrondo, Oliver
    Larranaga, Igor
    Arrospide, Arantzazu
    Martinez-Lage, Pablo
    Soto-Gordoa, Myriam
    ALZHEIMERS RESEARCH & THERAPY, 2020, 12 (01)
  • [4] Effect Size Analyses of Souvenaid in Patients with Alzheimer's Disease
    Cummings, Jeffrey
    Scheltens, Philip
    McKeith, Ian
    Blesa, Rafael
    Harrison, John E.
    Bertolucci, Paulo H. F.
    Rockwood, Kenneth
    Wilkinson, David
    Wijker, Wouter
    Bennett, David A.
    Shah, Raj C.
    JOURNAL OF ALZHEIMERS DISEASE, 2017, 55 (03) : 1131 - 1139
  • [5] A systematic review and meta-analysis of the clinical effects of Souvenaid in patients with Alzheimer's disease
    Shim, YongSoo
    Yoon, Bora
    Na, Seunghee
    Lim, Eun Ye
    Hong, Yun Jeong
    Yang, Dong Won
    ASIA PACIFIC JOURNAL OF CLINICAL NUTRITION, 2021, 30 (01) : 30 - 41
  • [6] The use of hippocampal grading as a biomarker for preclinical and prodromal Alzheimer's disease
    Morrison, Cassandra
    Dadar, Mahsa
    Shafiee, Neda
    Collins, D. Louis
    HUMAN BRAIN MAPPING, 2023, 44 (08) : 3147 - 3157
  • [7] The efficacy of supplementation with the novel medical food, Souvenaid, in patients with Alzheimer's disease: A systematic review and meta-analysis of randomized clinical trials
    Onakpoya, Igho J.
    Heneghan, Carl J.
    NUTRITIONAL NEUROSCIENCE, 2017, 20 (04) : 219 - 227
  • [8] Exploring effects of Souvenaid on cerebral glucose metabolism in Alzheimer's disease
    Scheltens, Nienke M. E.
    Briels, Casper T.
    Yaqub, Maqsood
    Barkhof, Frederik
    Boellaard, Ronald
    van der Flier, Wiesje M.
    Schwarte, Lothar A.
    Teunissen, Charlotte E.
    Attali, Amos
    Broersen, Laus M.
    van Berckel, Bart N. M.
    Scheltens, Philip
    ALZHEIMERS & DEMENTIA-TRANSLATIONAL RESEARCH & CLINICAL INTERVENTIONS, 2019, 5 (01) : 492 - 500
  • [9] The impact of institution use on the wellbeing of Alzheimer's disease patients and their caregivers
    Rapp, Thomas
    Apouey, Benedicte H.
    Senik, Claudia
    SOCIAL SCIENCE & MEDICINE, 2018, 207 : 1 - 10
  • [10] A feasibility trial of gamma sensory flicker for patients with prodromal Alzheimer's disease
    He, Qiliang
    Colon-Motas, Kay M.
    Pybus, Alyssa F.
    Piendel, Lydia
    Seppa, Jonna K.
    Walker, Margaret L.
    Manzanares, Cecelia M.
    Qiu, Deqiang
    Miocinovic, Svjetlana
    Wood, Levi B.
    Levey, Allan I.
    Lah, James J.
    Singer, Annabelle C.
    ALZHEIMERS & DEMENTIA-TRANSLATIONAL RESEARCH & CLINICAL INTERVENTIONS, 2021, 7 (01)
12345